EMD-25209

Single-particle
4.3 Å
EMD-25209
3D View Gallery
Deposition: 27/10/2021
Map released: 08/12/2021
Last modified: 02/02/2022
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-25209
Download
3D volume (map.gz) Experimental metadata (xml)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7sn2 summary report (pdf.gz) Map and 7sn2 FULL report (pdf.gz)
EMICSS annotations (xml)

Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab

EMD-25209

Single-particle
4.3 Å
EMD-25209
3D View Gallery
Deposition: 27/10/2021
Map released: 08/12/2021
Last modified: 02/02/2022
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: SARS-CoV-2_Hexapro in complex with neutralizing antibody C1C-A3 Fab from human patient
Fitted models: 7sn2

Deposition Authors: Pan J , Abraham J , Yang P , Shankar S
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.
Nabel KG , Clark SA , Shankar S , Pan J , Clark LE , Yang P , Coscia A , McKay LGA , Varnum HH, Brusic V, Tolan NV , Zhou G, Desjardins M , Turbett SE , Kanjilal S , Sherman AC , Dighe A, LaRocque RC , Ryan ET, Tylek C, Cohen-Solal JF , Darcy AT, Tavella D , Clabbers A , Fan Y, Griffiths A , Correia IR , Seagal J , Baden LR, Charles RC, Abraham J
(2022) Science , 375 , eabl6251 - eabl6251
PUBMED: 34855508
DOI: doi:10.1126/science.abl6251
ISSN: 1095-9203
ASTM: SCIEAS